CURRENT REPORT

Company

Raphael Pharmaceutical Inc.

Filed

March 28, 2023

Period of Report

March 27, 2023

Accession Number

0001213900-23-023667

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →